Angiotensin II Receptor Blocker (ARBs) API Market Report

Global and Region Angiotensin II Receptor Blocker (ARBs) API Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 01, 2022
  • PAGES：203
  • REPORT CODE：GMM977413
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Angiotensin II Receptor Blocker (ARBs) API market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Angiotensin II Receptor Blocker (ARBs) APImarket, defines the market attractiveness level of Angiotensin II Receptor Blocker (ARBs) API market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Angiotensin II Receptor Blocker (ARBs) API industry, describes the types of Angiotensin II Receptor Blocker (ARBs) API market, the applications of major players and the market size, and deeply analyzes the current situation of the global Angiotensin II Receptor Blocker (ARBs) API market and the development prospects and opportunities of Angiotensin II Receptor Blocker (ARBs) API industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Angiotensin II Receptor Blocker (ARBs) API market in Chapter 13.

    By Player:

    • Huahai Pharmaceutical

    • Second Pharma

    • Viatris

    • Jiangxi Synergy Pharmaceutical

    • Teva Pharmaceutical

    • Kinglyuan Pharmaceutical

    • Tianyu Pharma

    • Rundu Pharma

    • Apeloa

    • Menovo

    • Aurobindo Pharma

    By Type:

    • Valsartan

    • Irbesartan

    • Telmisartan

    • Losartan

    • Candesartan

    • Olmesartan

    • Others

    By End-User:

    • Essential Hypertension

    • Secondary Hypertension

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Angiotensin II Receptor Blocker (ARBs) API Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Angiotensin II Receptor Blocker (ARBs) API Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Angiotensin II Receptor Blocker (ARBs) API Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Angiotensin II Receptor Blocker (ARBs) API Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Angiotensin II Receptor Blocker (ARBs) API Market Analysis and Outlook to 2022

    • 7.1 Global Angiotensin II Receptor Blocker (ARBs) API Consumption (2017-2022)

    • 7.2 United States Angiotensin II Receptor Blocker (ARBs) API Consumption (2017-2022)

    • 7.3 Europe Angiotensin II Receptor Blocker (ARBs) API Consumption (2017-2022)

    • 7.4 China Angiotensin II Receptor Blocker (ARBs) API Consumption (2017-2022)

    • 7.5 Japan Angiotensin II Receptor Blocker (ARBs) API Consumption (2017-2022)

    • 7.6 India Angiotensin II Receptor Blocker (ARBs) API Consumption (2017-2022)

    • 7.7 South Korea Angiotensin II Receptor Blocker (ARBs) API Consumption (2017-2022)

    8 Region and Country-wise Angiotensin II Receptor Blocker (ARBs) API Market Analysis and Outlook to 2028

    • 8.1 Global Angiotensin II Receptor Blocker (ARBs) API Consumption Forecast (2022-2028)

    • 8.2 United States Angiotensin II Receptor Blocker (ARBs) API Consumption Forecast (2022-2028)

    • 8.3 Europe Angiotensin II Receptor Blocker (ARBs) API Consumption Forecast (2022-2028)

    • 8.4 China Angiotensin II Receptor Blocker (ARBs) API Consumption Forecast (2022-2028)

    • 8.5 Japan Angiotensin II Receptor Blocker (ARBs) API Consumption Forecast (2022-2028)

    • 8.6 India Angiotensin II Receptor Blocker (ARBs) API Consumption Forecast (2022-2028)

    • 8.7 South Korea Angiotensin II Receptor Blocker (ARBs) API Consumption Forecast (2022-2028)

    9 Global Angiotensin II Receptor Blocker (ARBs) API Market Outlook by Types and Applications to 2022

    • 9.1 Global Angiotensin II Receptor Blocker (ARBs) API Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Valsartan Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Irbesartan Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Telmisartan Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Losartan Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Candesartan Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global Olmesartan Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Angiotensin II Receptor Blocker (ARBs) API Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Essential Hypertension Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Secondary Hypertension Consumption and Growth Rate (2017-2022)

    10 Global Angiotensin II Receptor Blocker (ARBs) API Market Outlook by Types and Applications to 2028

    • 10.1 Global Angiotensin II Receptor Blocker (ARBs) API Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Valsartan Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Irbesartan Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Telmisartan Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Losartan Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Candesartan Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.6 Global Olmesartan Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.7 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Angiotensin II Receptor Blocker (ARBs) API Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Essential Hypertension Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Secondary Hypertension Consumption Forecast and Growth Rate (2022-2028)

    11 Global Angiotensin II Receptor Blocker (ARBs) API Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Angiotensin II Receptor Blocker (ARBs) API Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Angiotensin II Receptor Blocker (ARBs) API Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Angiotensin II Receptor Blocker (ARBs) API Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Angiotensin II Receptor Blocker (ARBs) API Market Competitive Analysis

    • 14.1 Huahai Pharmaceutical

      • 14.1.1 Huahai Pharmaceutical Company Details

      • 14.1.2 Huahai Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Huahai Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product and Service

    • 14.2 Second Pharma

      • 14.2.1 Second Pharma Company Details

      • 14.2.2 Second Pharma Angiotensin II Receptor Blocker (ARBs) API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Second Pharma Angiotensin II Receptor Blocker (ARBs) API Product and Service

    • 14.3 Viatris

      • 14.3.1 Viatris Company Details

      • 14.3.2 Viatris Angiotensin II Receptor Blocker (ARBs) API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Viatris Angiotensin II Receptor Blocker (ARBs) API Product and Service

    • 14.4 Jiangxi Synergy Pharmaceutical

      • 14.4.1 Jiangxi Synergy Pharmaceutical Company Details

      • 14.4.2 Jiangxi Synergy Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Jiangxi Synergy Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product and Service

    • 14.5 Teva Pharmaceutical

      • 14.5.1 Teva Pharmaceutical Company Details

      • 14.5.2 Teva Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Teva Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product and Service

    • 14.6 Kinglyuan Pharmaceutical

      • 14.6.1 Kinglyuan Pharmaceutical Company Details

      • 14.6.2 Kinglyuan Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Kinglyuan Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product and Service

    • 14.7 Tianyu Pharma

      • 14.7.1 Tianyu Pharma Company Details

      • 14.7.2 Tianyu Pharma Angiotensin II Receptor Blocker (ARBs) API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Tianyu Pharma Angiotensin II Receptor Blocker (ARBs) API Product and Service

    • 14.8 Rundu Pharma

      • 14.8.1 Rundu Pharma Company Details

      • 14.8.2 Rundu Pharma Angiotensin II Receptor Blocker (ARBs) API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Rundu Pharma Angiotensin II Receptor Blocker (ARBs) API Product and Service

    • 14.9 Apeloa

      • 14.9.1 Apeloa Company Details

      • 14.9.2 Apeloa Angiotensin II Receptor Blocker (ARBs) API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Apeloa Angiotensin II Receptor Blocker (ARBs) API Product and Service

    • 14.10 Menovo

      • 14.10.1 Menovo Company Details

      • 14.10.2 Menovo Angiotensin II Receptor Blocker (ARBs) API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Menovo Angiotensin II Receptor Blocker (ARBs) API Product and Service

    • 14.11 Aurobindo Pharma

      • 14.11.1 Aurobindo Pharma Company Details

      • 14.11.2 Aurobindo Pharma Angiotensin II Receptor Blocker (ARBs) API Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Aurobindo Pharma Angiotensin II Receptor Blocker (ARBs) API Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Angiotensin II Receptor Blocker (ARBs) API

    • Figure Angiotensin II Receptor Blocker (ARBs) API Picture

    • Table Global Angiotensin II Receptor Blocker (ARBs) API Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Angiotensin II Receptor Blocker (ARBs) API Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Angiotensin II Receptor Blocker (ARBs) API Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Angiotensin II Receptor Blocker (ARBs) API Consumption by Country (2017-2022)

    • Figure United States Angiotensin II Receptor Blocker (ARBs) API Consumption and Growth Rate (2017-2022)

    • Table Europe Angiotensin II Receptor Blocker (ARBs) API Consumption and Growth Rate (2017-2022)

    • Figure China Angiotensin II Receptor Blocker (ARBs) API Consumption and Growth Rate (2017-2022)

    • Figure Japan Angiotensin II Receptor Blocker (ARBs) API Consumption and Growth Rate (2017-2022)

    • Figure India Angiotensin II Receptor Blocker (ARBs) API Consumption and Growth Rate (2017-2022)

    • Figure South Korea Angiotensin II Receptor Blocker (ARBs) API Consumption and Growth Rate (2017-2022)

    • Figure Global Angiotensin II Receptor Blocker (ARBs) API Consumption Forecast by Country (2022-2028)

    • Figure United States Angiotensin II Receptor Blocker (ARBs) API Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Angiotensin II Receptor Blocker (ARBs) API Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Angiotensin II Receptor Blocker (ARBs) API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Angiotensin II Receptor Blocker (ARBs) API Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Angiotensin II Receptor Blocker (ARBs) API Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Angiotensin II Receptor Blocker (ARBs) API Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Valsartan Consumption and Growth Rate (2017-2022)

    • Figure Global Irbesartan Consumption and Growth Rate (2017-2022)

    • Figure Global Telmisartan Consumption and Growth Rate (2017-2022)

    • Figure Global Losartan Consumption and Growth Rate (2017-2022)

    • Figure Global Candesartan Consumption and Growth Rate (2017-2022)

    • Figure Global Olmesartan Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Essential Hypertension Consumption and Growth Rate (2017-2022)

    • Figure Global Secondary Hypertension Consumption and Growth Rate (2017-2022)

    • Figure Global Valsartan Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Irbesartan Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Telmisartan Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Losartan Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Candesartan Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Olmesartan Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Essential Hypertension Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Secondary Hypertension Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Angiotensin II Receptor Blocker (ARBs) API Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Angiotensin II Receptor Blocker (ARBs) API Export by Region (Top 5 Countries) (2017-2028)

    • Table Huahai Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Huahai Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Huahai Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product and Service

    • Table Second Pharma (Foundation Year, Company Profile and etc.)

    • Table Second Pharma Angiotensin II Receptor Blocker (ARBs) API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Second Pharma Angiotensin II Receptor Blocker (ARBs) API Product and Service

    • Table Viatris (Foundation Year, Company Profile and etc.)

    • Table Viatris Angiotensin II Receptor Blocker (ARBs) API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Viatris Angiotensin II Receptor Blocker (ARBs) API Product and Service

    • Table Jiangxi Synergy Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Jiangxi Synergy Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Jiangxi Synergy Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product and Service

    • Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product and Service

    • Table Kinglyuan Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Kinglyuan Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Kinglyuan Pharmaceutical Angiotensin II Receptor Blocker (ARBs) API Product and Service

    • Table Tianyu Pharma (Foundation Year, Company Profile and etc.)

    • Table Tianyu Pharma Angiotensin II Receptor Blocker (ARBs) API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tianyu Pharma Angiotensin II Receptor Blocker (ARBs) API Product and Service

    • Table Rundu Pharma (Foundation Year, Company Profile and etc.)

    • Table Rundu Pharma Angiotensin II Receptor Blocker (ARBs) API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Rundu Pharma Angiotensin II Receptor Blocker (ARBs) API Product and Service

    • Table Apeloa (Foundation Year, Company Profile and etc.)

    • Table Apeloa Angiotensin II Receptor Blocker (ARBs) API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Apeloa Angiotensin II Receptor Blocker (ARBs) API Product and Service

    • Table Menovo (Foundation Year, Company Profile and etc.)

    • Table Menovo Angiotensin II Receptor Blocker (ARBs) API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Menovo Angiotensin II Receptor Blocker (ARBs) API Product and Service

    • Table Aurobindo Pharma (Foundation Year, Company Profile and etc.)

    • Table Aurobindo Pharma Angiotensin II Receptor Blocker (ARBs) API Sales, Price, Value and Gross Profit (2017-2022)

    • Table Aurobindo Pharma Angiotensin II Receptor Blocker (ARBs) API Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US